share_log

HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Raises Price Target to $14

HC Wainwright & Co. Maintains Buy on Acurx Pharmaceuticals, Raises Price Target to $14

HC Wainwright & Co.维持对Acurx Pharmicals的买入,将目标股价提高至14美元
Benzinga ·  2023/12/15 06:36

HC Wainwright & Co. analyst Ed Arce maintains Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and raises the price target from $13 to $14.

HC Wainwright & Co. 分析师埃德·阿斯维持Acurx Pharmicals(纳斯达克股票代码:ACXP)的买入,并将目标股价从13美元上调至14美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发